# [18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial

> **NCT04727632** · EARLY_PHASE1 · TERMINATED · sponsor: **University of Utah** · enrollment: 2 (actual)

## Conditions studied

- Estrogen Receptor Positive Breast Cancer

## Interventions

- **DRUG:** [18F]Fluoroestradiol (FES) PET/CT

## Key facts

- **NCT ID:** NCT04727632
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-03-31
- **Primary completion:** 2023-09-14
- **Final completion:** 2024-07-30
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** It was not feasible to perform FES PET/CT
- **Last updated:** 2024-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04727632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04727632, "[18F]Fluoroestradiol-PET/CT Companion Imaging Study to the FORESEE Trial". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04727632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*